Biotech Archives - Page 18 of 61 - Life Sciences Times

Antares Therapeutics Launches with $177 Million to Advance First-in-Class Precision Medicines

June 10, 2025

European Commission Approves Alnylam’s AMVUTTRA for ATTR Amyloidosis with Cardiomyopathy

June 9, 2025

Upendra Mishra’s After the Fall Now Available on Amazon, Marking a Bold New Entry into the Transformational Book Market

June 7, 2025

THIS WEEK'S STORIES

Innospera Pharma Appoints Dr. Glenn Crater as Chief Medical Officer to Guide Lead Drug Candidate Into Clinical Trials

June 9, 2025

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

June 5, 2025

Antares Therapeutics Launches with $177 Million to Advance First-in-Class Precision Medicines

June 10, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Biotech

Nu-Tek BioSciences Highlights Animal-Free Innovations at BIO International Convention 2025

Emulate Launches AVA Emulation System, Pioneering High-Throughput Organ-Chip Platform to Accelerate Drug Development

Enveric Biosciences Secures U.S. Patent for New Class of Low-Hallucinogenic Compounds Targeting Mental Health Disorders

IonQ, AstraZeneca, AWS, and NVIDIA Achieve 20x Speedup in Quantum-Accelerated Drug Development Workflow

Phare Bio Chosen for Google.org Accelerator to Advance Open-Access AI Antibiotic Discovery Platform

Most Read

Windsor Regional Hospital Expands Cancer Services with New Modular Radiation Vault

UCP Merchant Medicine Appoints Chris Lukasiak as CEO to Lead Next Phase of Growth

Former White House Physician Dr. Jennifer Peña Named Chief Medical Officer at Wisp

MedEvolve Appoints Matt Seefeld as CEO to Lead Next Phase of Growth and Innovation

EDITOR PICKS

Antares Therapeutics Launches with $177 Million to Advance First-in-Class Precision Medicines

European Commission Approves Alnylam’s AMVUTTRA for ATTR Amyloidosis with Cardiomyopathy

Upendra Mishra’s After the Fall Now Available on Amazon, Marking a Bold New Entry into the Transformational Book Market

THIS WEEK'S STORIES

Innospera Pharma Appoints Dr. Glenn Crater as Chief Medical Officer to Guide Lead Drug Candidate Into Clinical Trials

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

Antares Therapeutics Launches with $177 Million to Advance First-in-Class Precision Medicines

POPULAR CATEGORY

ABOUT US

FOLLOW US